CORONAVIRUS (COVID-19)

HOPA has been closely monitoring the coronavirus and its impact on the pharmacist community. As a most-valued front-line responder, HOPA is committed to connecting you to the most current resources and information you need to support your patients.

Resources – Cancer Patients

• NCI COVID-19 Patient Resources
• ASCO COVID-19 Patient Care Information
• ASCO Cancer.Net Patient Information
• ACS COVID-10 and Cancer
• ONS COVID-19 Patient Care Resources

Resources – Healthcare Providers

Pharmacist

• APhA: Pharmacists’ Guide to Coronavirus
• ASHP COVID-19 Resource Center
• ACCP COVID-19 Updates
• Pharmacy Times Coronavirus Resource Center
• Editorial: Role of the Clinical Pharmacist during COVID-19
• ASHP Drug Shortages

Oncology

• ASCO Coronavirus Resources
• NCCN COVID-19 Resources
• ESMO – COVID-19 and Cancer
• ONS COVID-19 Resources
• NCI Guidance for Researchers

Advocacy

• Sign-on Letters
  • Include Pharmacists and Medically Underserved Areas Enhancement Act in COVID-19 Legislation
  • Pharmacy Organizations Joint Policy to Combat the COVID-19 Pandemic Updated 4-3-20
  • Pharmacy Letter to CMS on COVID-19
  • Pharmacy Letter to FDA on COVID-19
• COVID-19 Legislation Explained
  • Phase I-Coronavirus Preparedness and Response Supplemental Appropriations Act
  • Phase II-Families First Coronavirus Response Act
  • Phase III-Coronavirus Aid, Relief, and Economic Security (CARES) Act
  • Phase III-Summary of Economic Provisions in the CARES Act
  • Summary of Paycheck Protection Program and Health Care Enhancement Act (“COVID 3.5”)

Government Agencies

• CDC
  • Information for Healthcare Professionals
  • Information for Laboratories
  • Guidance to Pharmacies and Pharmacy Staff
  • Guidance on Maintaining Childhood Immunizations
• WHO
  • Guidance for Health Workers